Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 1 August 1986:
Vol. 233. no. 4763, pp. 566 - 569
DOI: 10.1126/science.3726549
Prev | Table of Contents | Next

Articles

Science, Vol 233, Issue 4763, 566-569
Copyright © 1986 by American Association for the Advancement of Science

articles

A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro

RP Nordan and M Potter

Plasmacytoma (PCT) cell lines dependent for proliferation and survival on a factor elaborated by the murine macrophage cell line, P388D1, were established in vitro. Adherent peritoneal cells induced by pristane produced 50-fold greater amounts of this activity in vitro than did resident cells. The molecules responsible for plasmacytoma growth were distinct from a number of characterized factors including interleukin-1, -2, and -3, macrophage colony-stimulating factor, B-cell stimulatory factor-1, B-cell growth factor II, epidermal growth factor, transforming growth factor-beta, and gamma- and beta-interferon, none of which were able to support the growth of the factor-dependent PCT cell lines. These results suggest that PCT growth factor may be a novel factor that has not been previously characterized and, further, that its production is associated with the pristane-induced, chronic peritoneal inflammatory response that precedes plasmacytoma formation.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Effects of T lymphocytes, interleukin-1, and interleukin-6 on renal fibrosis in canine end-stage renal disease.
J.-Y. Yhee, C.-H. Yu, J.-H. Kim, and J.-H. Sur (2008)
J Vet Diagn Invest 20, 585-592
   Abstract »    Full Text »    PDF »
Terminal B cell differentiation is skewed by deregulated interleukin-6 secretion in {beta}2 integrin-deficient mice.
T. Peters, W. Bloch, C. Wickenhauser, S. Tawadros, T. Oreshkova, D. Kess, T. Krieg, W. Muller, and K. Scharffetter-Kochanek (2006)
J. Leukoc. Biol. 80, 599-607
   Abstract »    Full Text »    PDF »
Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.
V. Bliskovsky, E. S. Ramsay, J. Scott, W. DuBois, W. Shi, S. Zhang, X. Qian, D. R. Lowy, and B. A. Mock (2003)
PNAS 100, 14982-14987
   Abstract »    Full Text »    PDF »
The myelin basic protein gene is expressed in differentiated blood cell lineages and in hemopoietic progenitors.
M. C. Marty, F. Alliot, J. Rutin, R. Fritz, D. Trisler, and B. Pessac (2002)
PNAS 99, 8856-8861
   Abstract »    Full Text »    PDF »
Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms.
D. Markine-Goriaynoff, T. D. Nguyen, G. Bigaignon, J. Van Snick, and J.-P. Coutelier (2001)
Int. Immunol. 13, 1185-1192
   Abstract »    Full Text »    PDF »
Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas.
R. Rawat, G. J. Rainey, C. D. Thompson, M. R. Frazier-Jessen, R. T. Brown, and R. P. Nordan (2000)
Blood 96, 3514-3521
   Abstract »    Full Text »    PDF »
Biphasic Ocular Inflammatory Response to Endotoxin-Induced Uveitis in the Mouse.
D. F. Shen, M. A. Chang, D. M. Matteson, R. Buggage, A. T. Kozhich, and C.-C. Chan (2000)
Arch Ophthalmol 118, 521-527
   Abstract »    Full Text »    PDF »
A Model that Reproduces Syndromes Associated with Human Multiple Myeloma in Nonirradiated SCID Mice.
B. E. Barton, J. Cullison, J. Jackson, and T. Murphy (2000)
Experimental Biology and Medicine 223, 190-197
   Abstract »    Full Text »
Murine plasmacytomas, carrier of the t(12;15) chromosomal translocation, develop from immature/mature B cells not from differentiated plasma cells.
S. Ohno, J.-i. Hayakawa, N. Hashimoto, and F. Wiener (1999)
Carcinogenesis 20, 529-538
   Abstract »    Full Text »    PDF »
The STAT3-independent Signaling Pathway by Glycoprotein 130 in Hepatic Cells.
C.-f. Lai, J. Ripperger, Y. Wang, H. Kim, R. B. Hawley, and H. Baumann (1999)
J. Biol. Chem. 274, 7793-7802
   Abstract »    Full Text »    PDF »
Interleukin 6 Influences Germinal Center Development and Antibody Production via a Contribution of C3 Complement Component.
M. Kopf, S. Herren, M. V. Wiles, M. B. Pepys, and M. H. Kosco-Vilbois (1998)
J. Exp. Med. 188, 1895-1906
   Abstract »    Full Text »    PDF »
Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus.
H. B. Richards, M. Satoh, M. Shaw, C. Libert, V. Poli, and W. H. Reeves (1998)
J. Exp. Med. 188, 985-990
   Abstract »    Full Text »    PDF »
Human CD34+ Bone Marrow Cells Regulate Stromal Production of Interleukin-6 and Granulocyte Colony-Stimulating Factor and Increase the Colony-Stimulating Activity of Stroma.
P. Gupta, B. R. Blazar, K. Gupta, and C. M. Verfaillie (1998)
Blood 91, 3724-3733
   Abstract »    Full Text »    PDF »
Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
S. Zhang, E. S. Ramsay, and B. A. Mock (1998)
PNAS 95, 2429-2434
   Abstract »    Full Text »    PDF »
Ectopic Expression of the Erythropoietin Receptor in a Murine Interleukin-6-Dependent Plasmacytoma Cell Line (TEPC-2027) Confers Proliferative Responsiveness to Erythropoietin.
F. Feger, A. Dubart, C. Lacout, I. Dusanter-Fourt, P. Mayeux, W. Vainchenker, and D. Dumenil (1997)
Blood 89, 435-445
   Abstract »    Full Text »    PDF »
A Di-leucine Motif and an Upstream Serine in the Interleukin-6 (IL-6) Signal Transducer gp130 Mediate Ligand-induced Endocytosis and Down-regulation of the IL-6 Receptor.
E. Dittrich, C. R. Haft, L. Muys, P. C. Heinrich, and L. Graeve (1996)
J. Biol. Chem. 271, 5487-5494
   Abstract »    Full Text »    PDF »
Cardiotrophin-1.
D. Pennica, K. J. Shaw, T. A. Swanson, M. W. Moore, D. L. Shelton, K. A. Zioncheck, A. Rosenthal, T. Taga, N. F. Paoni, and W. I. Wood (1995)
J. Biol. Chem. 270, 10915-10922
   Abstract »    Full Text »    PDF »
Two Distinct Signalling Pathways Are Involved in the Control of the Biphasic junB Transcription Induced by Interleukin-6 in the B Cell Hybridoma 7TD1.
R. Rezzonico, G. Ponzio, A.ès Loubat, D. Lallemand, A. Proudfoot, and B. Rossi (1995)
J. Biol. Chem. 270, 1261-1268
   Abstract »    Full Text »    PDF »
Enhanced Humoral Immunity in Common Variable Immunodeficiency after Long-Term Treatment with Polyethylene Glycol-Conjugated Interleukin-2.
C. Cunningham-Rundles, K. Kazbay, J. Hassett, Z. Zhou, and L. Mayer (1994)
N. Engl. J. Med. 331, 918-921
   Full Text »
Interleukin-6 Receptor and a Unique Mechanism of Its Signal Transduction.
T. Taga, M. Hibi, Y. Hirata, H. Yawata, S. Natsuka, K. Yasukawa, T. Totsuka, K. Yamasaki, T. Hirano, and T. Kishimoto (1989)
Cold Spring Harb Symp Quant Biol 54, 713-722
   Abstract »    PDF »
Effect of neuropeptides on production of inflammatory cytokines by human monocytes.
M Lotz, J. Vaughan, and D. Carson (1988)
Science 241, 1218-1221
   Abstract »    PDF »
Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.
K Yamasaki, T Taga, Y Hirata, H Yawata, Y Kawanishi, B Seed, T Taniguchi, T Hirano, and T Kishimoto (1988)
Science 241, 825-828
   Abstract »    PDF »
IL-6 transgenic mouse model for extraosseous plasmacytoma.
A. L. Kovalchuk, J. S. Kim, S. S. Park, A. E. Coleman, J. M. Ward, H. C. Morse III, T. Kishimoto, M. Potter, and S. Janz (2002)
PNAS 99, 1509-1514
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)